COPENHAGEN, Sept 7 (Reuters) – Novo Nordisk said on Monday that in a late-stage trial, 40.4% of children aged 6 to under 12 treated with semaglutide, the active ingredient in its blockbuster
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
‘All My Children’ actor Alan Dysert no more
Los Angeles [US], October 27 (ANI): Alan Dysert, who rose to fame with his role…
Kane crowned Ballon d'Or winner, Putellas wins women's award
VIDEO SHOWS: 2026 BALLON D'OR CEREMONY COMPLETE SCRIPT TO FOLLOW SHOWS: LONDON, ENGLAND, UNITED KINGDOM…
Cavaliers erase 15-point deficit, hand Timberwolves first loss in OT
Donovan Mitchell hit a go-ahead midrange jumper with 1:02 remaining in overtime as the host…
